Keyphrases
Tumor Growth
100%
Annexin A2 (ANXA2)
100%
Tumor Metastasis
100%
Mouse Lung
100%
Annexin
100%
Cancer Stem Cell Model
100%
Cationic Lipids
100%
Short Hairpin RNA Interference
100%
Lung Cancer Stem Cells
100%
Cationic Ligands
62%
Side Population Cells
56%
Sex-determining Region Y-box 2 (SOX2)
37%
Short Hairpin RNA (shRNA)
25%
MiRNA Target
25%
S100A10
25%
Resistant Phenotypes
18%
Tumor
12%
Therapeutic Efficacy
12%
Catenin
12%
Fluorescence Microscopy
12%
Tumor Weight
12%
Tumor Burden
12%
Lung Tumor
12%
Loading Efficiency
12%
Entrapment Efficiency
12%
Overexpressing
6%
Fluorescence Imaging
6%
MRNA Expression
6%
Chemotherapy
6%
Placebo
6%
Lung
6%
Knockdown
6%
Motility
6%
Protein Expression
6%
Quantitative PCR
6%
Cisplatin
6%
Western Blot
6%
Protein Level
6%
MRNA Level
6%
Xenograft
6%
Lung Cancer
6%
RNA Interference
6%
Oncogene
6%
5-fluorouracil (5-FU)
6%
C-Myc
6%
Docetaxel
6%
Cell Viability Assay
6%
Positive Charge
6%
Significant Loss
6%
Liposomal
6%
Resistance Phenotypes
6%
Camptothecin
6%
Cellular Burden
6%
C-Src
6%
Heterotetramer
6%
Side Population
6%
Mixed Population
6%
Orthotopic Lung Cancer Model
6%
Anticancer Target
6%
Gemcitabine
6%
Nanoparticulate
6%
Targeting Cancer Stem Cells
6%
Cancer Stem-like
6%
Biochemistry, Genetics and Molecular Biology
Small Hairpin RNA
100%
Tumor Progression
100%
RNA Interference
100%
Annexin A2
100%
Cancer Stem Cell
100%
Cationic Lipid
100%
Lipocortin
100%
Small Interfering RNA
100%
Side Population
90%
SOX2
54%
S100A10
36%
Catenin
18%
Fluorescence Microscopy
18%
Tumor Volume
18%
Protein Expression
9%
RNA
9%
Quantitative Reverse Transcription Polymerase Chain Reaction
9%
Cisplatin
9%
Anticancer
9%
Western Blot
9%
Cell Viability
9%
Proto Oncogene
9%
Oncogene C Myc
9%
Oncogene Src
9%
Fluorouracil
9%
Cell Oncogene
9%
Heterotetramer
9%
Messenger RNA
9%
Gemcitabine
9%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Growth
100%
Short Hairpin RNA
100%
Lipocortin 2
100%
Lung Cancer
100%
Lipocortin
100%
Neoplasm
45%
Lung Tumor
27%
Malignant Neoplasm
18%
Combination Therapy
18%
Catenin
18%
Fluorescence Microscopy
18%
Chemotherapy
9%
Placebo
9%
Western Blot
9%
Cell Viability
9%
Docetaxel
9%
Camptothecin
9%
Cisplatin
9%
Fluorouracil
9%
Gemcitabine
9%
Messenger RNA
9%